Development of a scalable adeno-associated virus purification process for gene therapy

Published: 25 November 2021
Åsa Hagner McWhirter

Watch the video or read the poster to learn how to:

  • Maximize the recovery of the affinity purification step.
  • Remove empty capsids without too much loss of full capsids
  • Avoid analytic pitfalls

Åsa holds a PhD in Medical Biochemistry from Uppsala University in 1999. Åsa has been with the company since 2003, working as a Downstream SME, with a broad and deep understanding of biopharmaceutical application challenges in the area of viral vectors and vaccines, as well as general protein purification and analysis.

Please note all fields marked with an * are mandatory

View article

Already registered? Login

If you have any problem accessing our content, please email